CELC
Closed
Celcuity Llc
12.49
-0.86 (-6.44%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 13.35
Day's Range: 12.48 - 13.6
Send
sign up or login to leave a comment!
When Written:
10.25
Celcuity LLC is a biotechnology company that specializes in developing and commercializing diagnostic tests to improve the treatment of cancer. The company was founded in 2012 and is based in Minneapolis, Minnesota.
Celcuity's proprietary technology platform, CELx, enables the identification of new cancer subtypes and the development of companion diagnostic tests that can identify patients who are most likely to benefit from specific cancer therapies. The company's diagnostic tests are designed to help physicians personalize cancer treatment for their patients, resulting in improved outcomes and reduced healthcare costs.
Celcuity's current focus is on breast cancer, but the company is also exploring the application of its technology platform to other types of cancer. The company has partnerships with several pharmaceutical companies, including Pfizer, to develop companion diagnostic tests for their cancer therapies.
Celcuity is a publicly traded company on the NASDAQ stock exchange under the ticker symbol "CELC".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Celcuity's proprietary technology platform, CELx, enables the identification of new cancer subtypes and the development of companion diagnostic tests that can identify patients who are most likely to benefit from specific cancer therapies. The company's diagnostic tests are designed to help physicians personalize cancer treatment for their patients, resulting in improved outcomes and reduced healthcare costs.
Celcuity's current focus is on breast cancer, but the company is also exploring the application of its technology platform to other types of cancer. The company has partnerships with several pharmaceutical companies, including Pfizer, to develop companion diagnostic tests for their cancer therapies.
Celcuity is a publicly traded company on the NASDAQ stock exchange under the ticker symbol "CELC".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








